REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome
Authors:
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 192, 114701
Abstract
No abstract availableKeywords
Funding Information
- University of California, San Francisco
- National Natural Science Foundation of China (81922078, 91739103)
- Research Grants Council, University Grants Committee
- Chinese University of Hong Kong
- Hong Kong Food and Health Bureau
This publication has 38 references indexed in Scilit:
- Circadian Gene Bmal1 Regulates Diurnal Oscillations of Ly6C hi Inflammatory MonocytesScience, 2013
- Circadian control of the immune systemNature Reviews Immunology, 2013
- Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonistsNature, 2012
- TLR‐induced NF‐κB activation regulates NLRP3 expression in murine macrophagesFEBS Letters, 2012
- The nuclear receptor REV-ERBα mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokinesProceedings of the National Academy of Sciences of the United States of America, 2011
- Two physically, functionally, and developmentally distinct peritoneal macrophage subsetsProceedings of the National Academy of Sciences, 2010
- Interleukin-18 controls energy homeostasis by suppressing appetite and feed efficiencyProceedings of the National Academy of Sciences, 2007
- Solubilizing Excipients in Oral and Injectable FormulationsPharmaceutical Research, 2004
- The Orphan Nuclear Receptor REV-ERBα Controls Circadian Transcription within the Positive Limb of the Mammalian Circadian OscillatorCell, 2002
- Resetting of Circadian Time in Peripheral Tissues by Glucocorticoid SignalingScience, 2000